Human papillomavirus-related disease in people with HIV

Current Opinion in HIV and AIDS

Volumn 4, Issue 1, 2009, Pages 52-56

  Palefsky, Joel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Anal intraepithelial neoplasia; Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus

Indexed keywords

ANTIRETROVIRUS AGENT; IMIQUIMOD;

ANUS CANCER; ANUS INTRAEPITHELIAL NEOPLASIA; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; DRUG MECHANISM; DYSPLASIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; MORBIDITY; MOUTH CANCER; PENIS CANCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ANTI-RETROVIRAL AGENTS; ANUS NEOPLASMS; CARCINOMA IN SITU; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; LASER THERAPY; MALE; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 67849091985     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32831a7246     Document Type: Review

References (36)

1. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285:1736-1745. (Pubitemid 32259908)
2. Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S. Cancer 2000; 88:1464-1469. (Pubitemid 30155186)
3. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001; 28:422-428. (Pubitemid 34033192)
4. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007; 165:1143-1153. Using an AIDS-Cancer registry match, this study showed that the relative hazard of developing anal cancer among HIV-positive individuals in San Francisco was 2.9 in the post-ART era compared with the pre-ART era. (Pubitemid 47233717)
5. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19:14-19. (Pubitemid 43032434)
6. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37:1563-1565.
7. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 2008; 48:491-499. This study showed an increase in the incidence of anal cancer in HIV-positive MSM being followed prospectively in the Multicenter AIDS Cohort Study in the post-ART era compared with the pre-ART era.
8. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22:1203-1211. This study showed a large increase in the incidence of anal cancer among HIVpositive individuals using data from a national French database, the French Hospital Database on HIV in the post-ART era compared with the pre-ART era.
9. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123:187-194. (Pubitemid 351705208)
10. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728-736. This study used SEER data from 13 geographic regions in the United States matched with data from the Adult and Adolescent Spectrum of HIV Disease Project and the HIV Outpatient Study showing an increase in the incidence of anal cancer increased in the post-ART era compared with the pre-ART era.
11. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356:1944-1956. This study convincingly described the link between HPV and a subset of oral cancers, particularly oropharyngeal cancer. (Pubitemid 46740304)
12. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100:407-420. This study delineated differences in risk factor profiles for HPV-positive and HPVnegative cancers, in which the former are primarily associated with sexual risk factors and the latter are associated primarily with tobacco and alcohol.
13. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35:1127-1134.
14. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407-1414. (Pubitemid 41800677)
15. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21:1457-1465. (Pubitemid 46988006)
16. Scott H, Khoury J, Moore BA, Weissman S. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008; 35:197-202. (Pubitemid 351158701)
17. McCloskey JC, Metcalf C, French MA, et al. The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS 2007; 18:538-542. (Pubitemid 351738941)
18. Chin-Hong PV, Berry JM, Cheng S-C, et al. A population-based study of human papillomavirus-associated anal neoplasia in HIV-positive and HIV-negative men using self-collected specimens: the TPOP study. Annals Int Med 2008; 149:300-306. This is the first population-based study of the prevalence of anal HPV infection and AIN in HIV-positive and HIV-negative MSM. The data were consistent with earlier studies from convenience cohorts. This study also showed that MSM with no prior experience with anal cytology screening could successfully auto-collect samples for anal cytology.
19. Kreuter A, Brockmeyer NH, Weissenborn SJ, et al. Penile intraepithelial neoplasia is frequent in HIV-positive men with anal dysplasia. J Invest Dermatol 2008; 128:2316-2324.
20. Veo CA, Saad SS, Nicolau SM, et al. Study on the prevalence of human papillomavirus in the anal canal of women with cervical intraepithelial neoplasia grade III. Eur J Obstet Gynecol Reprod Biol 2008; 140:103-107.
21. Richter KL, van Rensburg EJ, van Heerden WF, Boy SC. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. J Oral Pathol Med 2008; 37:555-559.
22. D'Souza G, Fakhry C, Sugar EA, et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 2007; 121:143-150. This study compared the natural history of oral and cervical HPV infection in a cohort of HIV-positive and high-risk HIV-negative women in the United States. The data showed that the prevalence and incidence of oral HPV infection were substantially lower than cervical HPV infection. (Pubitemid 46753862)
23. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183:383-391. (Pubitemid 32105597)
24. Palefsky J. Human papillomavirus and anal neoplasia. Current HIV/AIDS reports 2008; 5:78-85.
25. Cranston RD, Darragh TM, Holly EA, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr 2004; 36:915-920.
26. Lampinen TM, Miller ML, Chan K, et al. Randomized clinical evaluation of selfscreening for anal cancer precursors in men who have sex with men. Cytojournal 2006; 3:4.
27. Goldstone SE, Hundert JS, Huyett JW. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males. Dis Colon Rectum 2007; 50:565-575. This study showed that a high proportion of HGAIN lesions could be successfully treated in HIV-negative MSM using IRC.
28. Goldstone SE, Kawalek AZ, Huyett JW. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 2005; 48:1042-1054.
29. Cranston RD, Hirschowitz SL, Cortina G, Moe AA. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J STD AIDS 2008; 19:118-120. This retrospective analysis showed that a high proportion of HGAIN lesions could be successfully treated in HIV-positive MSM using IRC. (Pubitemid 351738818)
30. Stier EA, Goldstone SE, Berry JM, et al. Infrared coagulator treatment of highgrade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 2008; 47:56-61.
31. Wieland U, Brockmeyer NH, Weissenborn SJ, et al. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 2006; 142:1438-1444. (Pubitemid 44790637)
32. Kreuter A, Potthoff A, Brockmeyer NH, et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol 2008; 128:2078-2083. This study showed that treatment with topical imiquimod cleared a high proportion of intra-anal and peri-anal HGAIN in HIV-positive individuals. (Pubitemid 352001209)
33. Kreuter A, Wieland U, Gambichler T, et al. p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol 2007; 157:523-530. (Pubitemid 47256116)
34. Nathan M, Hickey N, Mayuranathan L, et al. Treatment of anal human papillomavirus-associated disease: a long term outcome study. Int J STD AIDS 2008; 19:445-449. This study was the first to describe the use of laser therapy to clear a high proportion of HGAIN lesions. Cure rates by HIV status were not reported, and the median time to cure was longer among HIV-positive patients compared with HIV-negative patients.
35. Chang GJ, Berry JM, Jay N, et al. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 2002; 45:453-458. (Pubitemid 34407722)
36. Pineda CE, Berry JM, Jay N, et al. High resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten year experience. Dis Col Rectum 2008; 1:829-835. This study revisits the efficacy of surgery to treat HIV-positive patients with extensive HGAIN. Combined with postoperative IRC to treat persistent or recurrent HGAIN, a high proportion (78%) of patients were cleared of HGAIN. These data suggest that treatment of patients with extensive HGAIN may also be successful.